Fig. 1From: Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised studyFlowchart of the study. 18F-FDG PET/CT: 18F-fluorodeoxyglucose positron emission tomography/Computed tomographyBack to article page